177 related articles for article (PubMed ID: 31053636)
41. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
[TBL] [Abstract][Full Text] [Related]
42. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
43. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
44. Incidence of brain metastasis at initial presentation of lung cancer.
Villano JL; Durbin EB; Normandeau C; Thakkar JP; Moirangthem V; Davis FG
Neuro Oncol; 2015 Jan; 17(1):122-8. PubMed ID: 24891450
[TBL] [Abstract][Full Text] [Related]
45. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract][Full Text] [Related]
46. Impact of reporting delay and reporting error on cancer incidence rates and trends.
Clegg LX; Feuer EJ; Midthune DN; Fay MP; Hankey BF
J Natl Cancer Inst; 2002 Oct; 94(20):1537-45. PubMed ID: 12381706
[TBL] [Abstract][Full Text] [Related]
47. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
[No Abstract] [Full Text] [Related]
48. Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden.
Fernandes AW; Wu B; Turner RM
J Med Econ; 2017 Nov; 20(11):1136-1147. PubMed ID: 28758857
[TBL] [Abstract][Full Text] [Related]
49. The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries.
Fisher KJ; Lee JH; Ferrante JM; McCarthy EP; Gonzalez EC; Chen R; Love-Jackson K; Roetzheim RG
Cancer; 2013 Aug; 119(16):2964-72. PubMed ID: 23677482
[TBL] [Abstract][Full Text] [Related]
50. The lifetime risk of developing breast cancer.
Feuer EJ; Wun LM; Boring CC; Flanders WD; Timmel MJ; Tong T
J Natl Cancer Inst; 1993 Jun; 85(11):892-7. PubMed ID: 8492317
[TBL] [Abstract][Full Text] [Related]
51. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
52. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
53. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
54. Costs of breast cancer recurrence after initial treatment for HR+, HER2-, high-risk early breast cancer: estimates from SEER-Medicare linked data.
Vitko AS; Martin P; Zhang S; Johnston A; Ohsfeldt R; Zheng S; Liepa AM
J Med Econ; 2024; 27(1):84-96. PubMed ID: 38059275
[TBL] [Abstract][Full Text] [Related]
55. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
[TBL] [Abstract][Full Text] [Related]
56. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
57. Patterns of skin metastases: a review of 25 years' experience at a single cancer center.
Wong CY; Helm MA; Helm TN; Zeitouni N
Int J Dermatol; 2014 Jan; 53(1):56-60. PubMed ID: 23432658
[TBL] [Abstract][Full Text] [Related]
58. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
59. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
60. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
